Abstract

The contents of four ciprofloxacin tablets products available in the private pharmacies of Mosul city were measured according to the British Pharmacopoeia (BP). Some biopharmaceutical parameters such as content uniformity, disintegration, and hardness were also measured for the same products. In addition, the antibacterial activity of these four products were assessed by microbiological assay on different types of gram negative bacteria in vitro. The results indicated that there is a little differences in the content uniformity of these products and they are within acceptable requirement of BP and United State Pharmacopoeia (USP). In the same manner, the weight variation, disintegration, and hardness were within acceptable range according to the BP and USP. The microbiological assay indicated that these different products produce approximately the same inhibition zones on the same bacterial type. The above results may be useful to predict the bioavailability of these different products .

Highlights

  • ‫تم قياس المحتوى الدوائي لأربعة منتجات من حبوب السيبروفلوآساسين مت وفرة ف ي الص يدليات الخاص ة لمدين ة الموص ل طبق ا‬ ‫آما تم إجراء بعض الفحوصات الحيوية الصيدلانية مثل تماثل الوزن و سرعة الاض محلال للحب وب‬. ‫لدستور الادوية البريطاني‬ ‫ بالإضافة لذلك تم قياس التأثير المضاد للبكتري ا له ذه المنتج ات باس تخدامها عل ى ع دة ان واع‬.‫و الصلابة لنفس المنتجات السابقة‬

  • ١- The samples of ciprofloxacin used is shown in table ١. ٢- Ciprofloxacin HCl standard powder was a gift from SDI company, Sammara, Iraq. ٣- Reagents used include ٠.١N HCl, acetonitrile, orthophosphoric acid, and triethylamine. ٤- Isolates of bacteria such as Escherichia coli, Klebsiella pneumonia, Proteus and Salmonella species were obtained from microbiology department, College of sciences, University of Mosul

  • A summary of the result of average uniformity of weight, % deviation from average weight, disintegration time, and hardness of four brands of ciprofloxacin tablets is shown in table ٣

Read more

Summary

Introduction

‫تم قياس المحتوى الدوائي لأربعة منتجات من حبوب السيبروفلوآساسين مت وفرة ف ي الص يدليات الخاص ة لمدين ة الموص ل طبق ا‬ ‫آما تم إجراء بعض الفحوصات الحيوية الصيدلانية مثل تماثل الوزن و سرعة الاض محلال للحب وب‬. ‫لدستور الادوية البريطاني‬ ‫ بالإضافة لذلك تم قياس التأثير المضاد للبكتري ا له ذه المنتج ات باس تخدامها عل ى ع دة ان واع‬.‫و الصلابة لنفس المنتجات السابقة‬. ‫من البكتريا السالبة خارج الجسم‬ ‫أظه رت النت ائج أن هن اك اختلاف ات بس يطة ف ي المحت وى ال دوائي له ذه المنتج ات وض من المس تويات المطلوب ة طبق ا لدس تور‬ ‫ بنفس الطريقة آانت نتائج تماثل الوزن و سرعة الانحلال و الصلابة ضمن المستويات المطلوبة‬.‫الأدوية البريطاني و الأمريكي‬ ‫ اظه ر التقي يم البيول وجي أن ه ذه المنتج ات المختلف ة تعم ل تقريب ا نف س الت أثير‬.‫و طبقا لدس تور الادوي ة البريط اني و الأمريك ي‬. Ciprofloxacin is one of the fluoroquinolones antibacterial drugs, originally developed because of their excellent activity against gram negative aerobic bacteria It has less activity against gram positive bacteria such as Streptococcus pneumoniae and Enterococcus. Ciprofloxacin is bactericidal and exhibit concentration-dependent bacterial killing[٣]

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.